IRC Seminar, presented by Professors Burgess, Micheli and Voss: "Corporate lean improvement programs in healthcare: Hitting the point, missing the target"
Date: 18th November 2020
Time: 12.00 pm - 13:00 pm
Location: Zoom Meeting (link included in email invitation)
Presenters: Dr Nicola Burgess, Professor Pietro Micheli, and Professor Chris Voss
|Date||18th November 2020|
|Time||12:00pm - 1:00pm|
This paper reports the findings of a longitudinal study of a corporate change program based on a process improvement approach, commonly known as lean. Our empirical context are public hospitals in the UK. Despite the number of studies focusing on lean within manufacturing and service sectors, most authors have tended to focus on individual projects that adopt principles and methods to deliver localized improvement. Much less has been done in relation to corporate change programs that span the whole organization.
It is often said that more than 70% of process improvement programs fail . Yet, for many operations management scholars the belief that organizations can and do benefit from lean is not in question; instead, it is argued that research should focus upon how to implement lean to ensure its success. As a consequence, research has developed rich insights about infrastructural and behavioral aspects to guide implementation. Key elements include: decisions about where to start a corporate lean program, how to build improvement capability, and how to involve different levels of management in decision making processes to foster alignment between local and corporate priorities. In healthcare, routinely engaging a diverse set of professionals towards a shared goal of improving the quality of patient care is crucial to avoid professional biases that can undermine the corporate improvement endeavor.
In this study, we extend research on corporate change programs by showing that the way performance is measured and whether alignment with corporate (and national) priorities is ensured will influence the effectiveness of the overall change program. Indeed, previous studies have shown that performance measurement practices can enable but also hinder improvement, especially in complex organizations. Also, failure to evidence operational and financial improvement can leave even the most embedded corporate lean program vulnerable to elimination. However, the literature has remained silent about how corporate change programs should seek to quantify and evidence impact in a meaningful way. Considering strategic alignment, corporate change programs are often disconnected from organizational priorities in an attempt to reduce potential negative influences (e.g., entrenched power dynamics and organizational norms and routines). At the same time, these programs are typically expected to quickly lead to improvements in performance and are blamed if better results cannot be demonstrated.
This study is built on a national evaluation of a partnership between the English NHS and the Virginia Mason Institute where five public English hospitals have been supported for five years to develop localized versions of the Virginia Mason Production System (akin to the Toyota Production System). The £12 million partnership was launched in 2015 by the (then) UK Health Secretary, Jeremy Hunt, and is now coming to an end.
The partnership is unusual in many ways, in particular for the unprecedented support of the regulator that has led to a regulator-healthcare provider relationship that is more relational and informal in its approach to governance than has been seen before.
Of particular interest is the early decision to not measure the five English hospitals using any additional indicators of performance (since UK hospitals are subject to a raft of national measures and targets already). While this made sense at the time, our data suggests that this left the five hospitals to their own devices when thinking about what to improve, why and how to measure success in a meaningful way. Ultimately, all five organisations have struggled to evidence the impact of their improvement work even though interviews with CEOs, senior managers, middle managers and frontline staff all concur that the improvement method has delivered significant benefits to the organisation including performance improvements and financial savings.
The research involved over 170 interviews and approximately 200 hours of observation across three years, a survey with approximately 350 responses as well as an extensive archive of quantitative process improvement data.
Our analysis focuses on the following aspects: the choice of areas to seek improvement (value streams); the degree of alignment with local, corporate and national priorities; decisions about what is measured and how; and extent to which performance measurement systems portray the success or otherwise of the change program in a meaningful way.
Outcomes and potential contributions
This research shows the importance of creating strategic alignment between the corporate change program and the local and national priorities, which are often cascaded through performance targets and indicators. We also demonstrate how learning should be a central part of corporate lean improvement programs in healthcare, and we identify three areas of tension or paradoxes in their design and implementation:
- Performance measurement paradox (to measure/not to measure)
- With no measurable goals, success can be cast in vague terms, improvement work can be ‘protected’ from external context and risk of failure is reduced
- However, with no measurable goals, it is difficult to evidence success and to create strategic alignment.
- Capability building and “performance paradox”
- The corporate change program was heavily weighted towards capability building rather than improving performance. Capability building was expected to happen through ‘fail forward fast’; however, many interviewees questioned whether this process was sufficiently ‘fast’ and whether some failures should have actually been avoided in the first place.
- The program regarded performance improvement not as a primary goal, but almost as an inevitable consequence with the prevailing notion that ‘all improvement is good.’ At the same time, weak links between the program and organizational and national priorities meant that some improvements were achieved in areas not regarded as key.
- Control – Autonomy paradox
- The method adopted was very prescriptive about how (e.g., process, tools, techniques), but hands-off in relation to what and why, as it wanted to promote autonomy and employee engagement.
- At the same time, errors were made and opportunities missed, and perhaps a stronger sense of (strategic) control should have been ensured.
A copy with full references can also be downloaded here: Corporate lean improvement programs in Healthcare
Dr Nicola Burgess is Reader in Healthcare Operations Management at Warwick Business School and Course Director for the Foundation Year programme, part of Warwick University’s widening participation strategy. Nicola's research activity has primarily focused in healthcare, conducting a number of formative and summative evaluations of service improvement initiatives within healthcare settings around the world. She is currently leading the national evaluation of the NHS partnership with Virginia Mason institute which is due to conclude in 2021. In May 2020 the evaluation was extended to capture how a systematic approach to quality improvement shaped the operational response of NHS hospitals to the COVID-19 pandemic.
Nicola has published widely in world leading journals such as Journal of Operations Management, Human Resource Management, European Journal of Operations Research British Journal of Management and the British Medical Journal.
Professor Pietro Micheli is Professor of Business Performance and Innovation at Warwick Business School, where he is also Director of the Distance Learning MBA. Previously, he was Senior Lecturer at Cranfield School of Management and Research Fellow at the Advanced Institute of Management (AIM) research in London. In 2009-2011 he was Director of the Commission for public sector evaluation in Rome. His research, consulting and advisory work focus on three main areas: strategy execution, performance measurement and management, and innovation management, particularly design thinking and digital transformation.
Over the past 15 years, he has collaborated with over 60 organizations, including BP, Emirates, KLM, Royal Dutch Shell, Tata Group, UK Cabinet Office, UK Department of Health, and the United Nations. As a researcher he has been a principal investigator and co-investigator in projects funded by several institutions, including EPSRC, NIHR, Design Council, and several private and public organizations. His research has resulted into the publication of 25 articles in top peer-reviewed journals (citations: 2,050 on Scopus; 4,800 on Google Scholar), three books, four reports, six case studies, and 27 business articles.
Professor Chris Voss is Professor of Operations Management Warwick Business School and Emeritus Professor of Operations Management at London Business School where he has served as deputy dean. Professor Voss gained his MBA and PhD from London Business School. He is a fellow of BAM, DSI, EurOMA and POMS and was elected distinguished scholar by the OM division of the Academy of Management in 2008. His current and recent research has included impact of Covid on supply chains, design of experience-centric services, service architecture and modularity, e-services, service supply chains and service innovation. Professor Voss is Associate Editor of the Journal of Service Research. His research has been published in: Journal of Operations Management, Journal of Service Management, Journal of Service Research, Journal of Service Marketing, Journal of Product Innovation Management, Decision Science Journal, International Journal of Operations and Production Management and others. He was co-founder and long-term chairman of the European Operations Management Association, and serves on several editorial boards.